Dr. Gadi Borkow obtained his Ph.D. from Tel Aviv University, Israel, in 1994, during which he studied the mode of action of hemorrhagins. His post-doctoral studies were conducted at McGill University, where he specialized in HIV-1. In 1998, Dr. Borkow joined the Hebrew University Institute of Clinical Immunology and AIDS Center, where he studied virological and immunological aspects of HIV-1 infection. Since 2004, Dr. Borkow has been the Chief Medical Scientist of Cupron Inc. and since 2017 he has also been the Chief Scientist and co-founder of MedCu Technologies Ltd. Dr. Borkow has published over 140 peer-reviewed manuscripts and serves as a reviewer of >50 scientific journals and on the Editorial Board of six scientific journals. Dr. Borkow’s studies include understanding the effects that copper ions have on intact and breached skin, how copper improves wound healing, and utilizing the beneficial properties of copper in medical devices and applications.
Dr. Gadi Borkow obtained his Ph.D. from Tel Aviv University, Israel, in 1994, during which he studied the mode of action of hemorrhagins. His post-doctoral studies were conducted at McGill University, where he specialized in HIV-1. In 1998, Dr. Borkow joined the Hebrew University Institute of Clinical Immunology and AIDS Center, where he studied virological and immunological aspects of HIV-1 infection. Since 2004, Dr. Borkow has been the Chief Medical Scientist of Cupron Inc. and since 2017 he has also been the Chief Scientist and co-founder of MedCu Technologies Ltd. Dr. Borkow has published over 140 peer-reviewed manuscripts and serves as a reviewer of >50 scientific journals and on the Editorial Board of six scientific journals. Dr. Borkow’s studies include understanding the effects that copper ions have on intact and breached skin, how copper improves wound healing, and utilizing the beneficial properties of copper in medical devices and applications.